NSC |
Compound |
Enrichment |
Correlation |
NSC 755295 |
2-(1-(3-chlorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide |
0.0199123109106642 |
0.46375554 |
NSC 756363 |
GW804482X |
0.0199123109106645 |
0.17803676 |
NSC 100880 |
Camptothecin |
0.0209467683758286 |
0.44972586 |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.0209467683758286 |
0.36714822 |
NSC 129757 |
Null |
0.0209467683758286 |
0.28384521 |
NSC 13151 |
Null |
0.0209467683758286 |
0.50242743 |
NSC 135880 |
Null |
0.0209467683758286 |
0.47194503 |
NSC 275647 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- |
0.0209467683758286 |
0.54858175 |
NSC 303861 |
L-Cysteine analog |
0.0209467683758286 |
0.56111277 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.0209467683758286 |
0.64192885 |